Companies similar to CELECOR
Sign up to Download

1-30 of 6,204,342 results

  • www.celecor.com
  • 1
  • 1
  • 21
Each year, 800,000 people in the United States have an acute myocardial infarction (AMI), or heart attack. We founded CeleCor Therapeutics to improve the treatment of ST-Segment Elevated Myocardial Infarctions (STEMI heart attacks) at the first point..
Relevance: 24.246178
  • www.esmrheart.com
  • 2
  • 2
ESMR or Extracorporeal Shockwave Myocardial Revascularization is also known as Non invasive Cardiac Angiogenesis therapy (Ni-CATh). ESMR therapy is a new non invasive therapy approach which uses Extracorporeal Shockwave technology to improve the..
Relevance: 22.57493
  • forcefieldtx.com
  • 1
  • 1
  • 6
Our aim is to revolutionise treatment following acute myocardial infarction and to prevent the cascade of events that may lead to subsequent heart failure. Professor Giacca's ground-breaking research is the first step in achieving this goal.".....
Relevance: 22.074257
  • www.regencor.com
  • 1
  • 9
Regencor is a regenerative medicine company focused on developing cardiac regenerative therapies that target myocardial infarction and heart failure. We have discovered and patented recombinant glycosylation variants of human circulating FSTL1 that..
Relevance: 21.978106
  • www.esmrtreatment.com
  • 1
  • 1
  • 1
With improvement in cardiovascular care, there is a rapidly growing group of patients who remain severely disabled by symptoms of myocardial ischemia but yet not amenable to conventional revascularization therapy. ESMR is a shockwave therapy given to..
Relevance: 21.931383
  • www.getmyostrain.com
  • 1
Myocardial Solutions is committed to helping people access MyoStrain through certified imaging centers such as the one found at Memorial MRI & Diagnostic. ​... Discover MyoStrain, a first-of-its-kind, 10-minute direct heart assessment that may help..
Relevance: 21.168062
  • adriakaim.co.jp
  • 1
  • 2
  • 5
Of the approximately 80,000 people in Japan each year who develop acute myocardial infarction, approximately 23,000 are said to develop chronic heart failure. Adriakaim aims to suppress the onset of chronic heart failure through application of a..
Relevance: 20.720892
  • recardio.eu
  • 2
  • 3
Recardio is developing novel therapies that modulate and utilize the body's own repair mechanisms in cardiovascular and other diseases. Our lead candidate Dutogliptin is intended to enable cardiac regeneration in patients with Acute Myocardial..
Relevance: 20.617073
  • www.heqettherapeutics.com
  • 1
We develop groundbreaking genetic medicines to reverse the damage of ischemic heart disease, the leading cause of death worldwide. Our therapeutic approach aims to regenerate the heart and life's promise... Heqet Therapeutics develops first-in-class..
Relevance: 19.648264
  • aiahope.com
  • 2
  • 1
  • 1
We provide remote real-time, continuous, long-term heart monitoring that enables early diagnosis of heart diseases in a cost-effective manner by automating 14 kinds of arrhythmia detection... We provide risk assessment and detection of coronary..
Relevance: 19.597914
  • cvdimaging.com
  • 1
CVDI, LLC has recently partnered with MicroVide, LLC a startup venture based in South Carolina for the licensing, development, and translation of imaging agents targeted at in vivo imaging matrix metalloproteinase (MMP) activation for the evaluation..
Relevance: 19.587946
  • rheoxtech.com
  • 1
Rheoxtech is a pre-clinical medical device company operating out of Portal Innovations, a life-science business accelerator located in Chicago, IL that is creating groundbreaking treatments for the Acute Myocardial Infarction Market- a wide-ranging..
Relevance: 19.53739
  • www.drpratapkumarpradhan.com
  • 7
Dr. Pratap Kumar Pradhan is an experienced Interventional Cardiologist in Bhubaneswar. He has been practising since 1995, and is currently attached to the Hi-Tech Medical College & Hospital (Rasulgarh), Utkal Heart Centre (Sahid Nagar) and Apollo..
Relevance: 19.433968
  • dionstub.com
  • 2
  • 2
Melbourne cardiologist Prof Dion Stub specialises in coronary and structural heart intervention at the Alfred Hospital & Cabrini Hospital in Melbourne... Prof. Dion Stub specialises in structural heart procedures including angioplasty, aortic valve..
Relevance: 19.230663
  • www.lifetimeheart.com
  • 2
  • 1
Lifetime Heart & Vascular focuses on the diagnosis and treatment of patients with cardiovascular issues. We are committed to providing excellent care for our patients through an established and comprehensive network of services and a high level of..
Relevance: 18.838522
  • www.macnew.org
  • 2
  • 1
MacNew.org licenses the MacNew, the leading self-administered heart disease-specific health-related quality of life instrument. We develop the MacNew, adopt the instrument for cultural settings and provide consultation for its use... The MacNew is..
Relevance: 18.773973
  • www.nourheart.com
  • 1
  • 1
  • 8
Nour Heart is a Connecticut-based biomedical company aimed at developing diagnostic and therapeutic products for the early detection, prevention, and treatment of myocardial ischemia in patients with ischemic heart disease... Nour Heart is currently..
Relevance: 18.752005
  • zora.fi
  • 1
  • 1
  • 11
We use mass spectrometry to identify markers of disease and develop them into robust, high-throughput, value-added clinical diagnostic tests which are commercialized together with our international partners or through our own reference laboratory in..
Relevance: 18.640308
  • retavase.com
  • 1
  • 2
RETAVASE is a tissue plasminogen activator (tPA) indicated for treatment of acute ST-elevation myocardial infarction (STEMI) to reduce the risk of death and heart failure... The only fixed-dose fibrinolytic for acute STEMI, RETAVASE is a recombinant..
Relevance: 18.505253
  • www.4teen4.de
  • 4
  • 2
  • 12
Cardiogenic shock is an acute and life-threatening medical emergency, usually caused by an acute myocardial injury, like a heart attack, resulting in left-ventricular dysfunction of the heart and subsequent inadequate oxygenated blood supply to the..
Relevance: 18.475765
  • www.yourheartsage.com
Carlsbad Medical Center is an Accredited Chest Pain Center with PCI by ACC Accreditation Services (American College of Cardiology)... Carlsbad Medical Center is designated as the official STEMI-receiving hospital in Eddy County. A STEMI (ST segment..
Relevance: 18.058006
  • www.cellprothera.com
  • 3
In 2002, a successful Proof of Concept clinical study led by Pr Philippe HENON - Founder and Director of IRHT Mulhouse - showing structural and functional regeneration of myocardial tissue as well as reperfusion of an infarcted zone after a recent..
Relevance: 17.580433
  • sercapharmaceuticals.com
  • 5
  • 9
Serca Pharmaceuticals is a biopharmaceutical company focusing on development of its lead drug candidate intended for use in a novel treatment of acute myocardial infarction... Serca Pharmaceuticals (Oslo, Norway) was established in 2018 based on..
Relevance: 17.541542
  • dalcorpharma.com
  • 1
  • 4
  • 15
DalCor Pharmaceuticals is a biopharmaceutical company focused on addressing cardiovascular disease, the greatest global healthcare burden. Our purpose is to deliver dalcetrapib, the first pharmacogenetic precision medicine in cardiovascular disease..
Relevance: 17.312014
  • www.yourheartsage.com
  • 1
Carlsbad Medical Center is designated as the official STEMI-receiving hospital in Eddy County. A STEMI (ST segment elevation myocardial infarction) is a serious heart attack in which a major artery to the heart is completely blocked... Carlsbad..
Relevance: 16.43509
  • www.bnr.org.bb
  • 13
  • 2
  • 7
The Barbados National Registry for Chronic Non-Communicable Disease (BNR) is a national surveillance system being conducted by the Chronic Disease Research Centre on behalf of the Ministry of Health. The BNR is made up of 3 registries: BNR-Stroke,..
Relevance: 16.312609
  • www.stentsavealife.com
  • 9
  • 15
  • 28
The Stent - Save a Life! global initiative aims to improve access to guideline complying therapy and the lifesaving indication of primary percutaneous coronary intervention (p-PCI), thereby reducing mortality and morbidity in patients suffering from..
Relevance: 16.294031
  • www.alphaomegacohort.org
  • 2
  • 1
The Alpha Omega Cohort is coordinated by researchers at Wageningen University, The Netherlands. The trial phase was sponsored by the Dutch Heart Foundation, National Institutes of Health, Unilever R&D (margarine development and distribution) and..
Relevance: 16.25748
  • valvention.com
  • 1
  • 1
HelixCardia™ is based on the concept of helically arranged myocardial fibers that connect cardiac apex to its base, providing a "positive-displacement" in systole and a "suction" during diastole. HelixCardia™ does not have any direct contact with..
Relevance: 16.14048
  • www.myocardialsolutions.com
  • 4
  • 2
  • 16
At Myocardial Solutions, we are working to standardize preventative heart care for large and unmet cardiac populations. Standardization enhances clinical efficiencies, reduces healthcare costs, offers new services, and improves reimbursement through..
Relevance: 16.030241